相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cellular Uptake of MCT1 Inhibitors AR-C155858 and AZD3965 and Their Effects on MCT-Mediated Transport of L-Lactate in Murine 4T1 Breast Tumor Cancer Cells
Xiaowen Guan et al.
AAPS JOURNAL (2019)
Development and validation of a liquid chromatography tandem mass spectrometry assay for AZD3965 in mouse plasma and tumor tissue: Application to pharmacokinetic and breast tumor xenograft studies
Xiaowen Guan et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Targeting Tumor Metabolism: A New Challenge to improve immunotherapy
Soumaya Kouidhi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Small-Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD): A Minireview
Guohua An
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
Richard A. Noble et al.
HAEMATOLOGICA (2017)
Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity
Nicola J. Curtis et al.
ONCOTARGET (2017)
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
Richard A. Noble et al.
HAEMATOLOGICA (2017)
A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumours.
Sarah E. R. Halford et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4
Candice Sun Hong et al.
CELL REPORTS (2016)
Small-molecule compounds exhibiting target-mediated drug disposition A case example of ABT-384
Guohua An et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Population pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 in healthy volunteers following single and multiple dose regimens
Guohua An et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2014)
Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Radoslaw Polanski et al.
CLINICAL CANCER RESEARCH (2014)
Synthesis and Structure Activity Relationships of Pteridine Dione and Trione Monocarboxylate Transporter 1 Inhibitors
Hui Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport
Becky M. Bola et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth, Angiogenesis and Metastasis
Suveera Dhup et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
The monocarboxylate transporter familyuStructure and functional characterization
Andrew P. Halestrap
IUBMB LIFE (2012)
The monocarboxylate transporter familyuRole and regulation
Andrew P. Halestrap et al.
IUBMB LIFE (2012)
Role of monocarboxylate transporters in human cancers: state of the art
Celine Pinheiro et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells
Hiroto Izumi et al.
CANCER SCIENCE (2011)
Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models
Xiaoyu Yan et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Prediction of Biliary Excretion in Rats and Humans Using Molecular Weight and Quantitative Structure-Pharmacokinetic Relationships
Xinning Yang et al.
AAPS JOURNAL (2009)
Overview of the proton-coupled MCT (SLC16A) family of transporters:: Characterization, function and role in the transport of the drug of abuse γ-hydroxybutyric acid
Marilyn E. Morris et al.
AAPS JOURNAL (2008)
The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse
Valquiria Bueno et al.
TRANSPLANTATION (2007)
Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: An in vitro study
Chaim B. Colen et al.
NEUROSURGERY (2006)
Potent blockers of the monocarboxylate transporter MCT1: Novel immunomodulatory compounds
SD Guile et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats
Young Jin Moon et al.
AAPS JOURNAL (2006)
Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition
DE Mager et al.
PHARMACEUTICAL RESEARCH (2005)
The SLC16 gene family -: from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond
AP Halestrap et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation
T Wajima et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2002)
General pharmacokinetic model for drugs exhibiting target-mediated drug disposition
DE Mager et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
分享论文
